Nitroglycerin ointment applied at bedtime for 2 years slightly increased bone mineral density in postmenopausal women states a study in JAMA. Read more at…
The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients according to a report in February’s Health Affairs. Read more here.
“The War Within: Preventing Suicide in the U.S. Military,” a report released by the Rand Corporation, states U.S. military officials should improve their efforts…
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women…
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…
Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
Read guest blogger Donna Cardillo’s thought-provoking article about when age comes into play during a nurse’s career. A recent New York Times article begged…
The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients according to a report in February’s Health Affairs. Read…
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…
Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…